Table 3.
Pairwise correlation analyses of the different PD-L1 antibody clones.
| Pairwise comparison in UCV | Pairwise comparison UCV/NOS same case | ||||
|---|---|---|---|---|---|
| TC | R | TC | R | ||
| SP263 | SP142 | 0.886 | SP263 UCV | SP263 NOS | 0.631 |
| SP263 | 22C3 | 0.886 | SP142 UCV | SP142 NOS | 0.538 |
| SP142 | 22C3 | 0.898 | 22C3 UCV | 22C3 NOS | 0.650 |
| TC H-score | TC H-Score | ||||
| SP263 | SP142 | 0.887 | SP263 UCV | SP263 NOS | 0.632 |
| SP263 | 22C3 | 0.886 | SP142 UCV | SP142 NOS | 0.491 |
| SP142 | 22C3 | 0.901 | 22C3 UCV | 22C3 NOS | 0.654 |
| IC | IC | ||||
| SP263 | SP142 | 0.780 | SP263 UCV | SP263 NOS | 0.876 |
| SP263 | 22C3 | 0.809 | SP142 UCV | SP142 NOS | 0.888 |
| SP142 | 22C3 | 0.855 | 22C3 UCV | 22C3 NOS | 0.919 |
UCV: urothelial carcinoma with divergent differentiation, NOS: pure urothelial carcinoma, TC: tumor cell analyses, IC: immune cell analyses.